Hypertension remains a leading contributor to cardiovascular disease, but advancements in its management are reshaping treatment strategies. This episode highlights the latest updates in hypertension guidelines, emerging therapies, and practical approaches pharmacists can use to optimize care. Don’t miss this chance to stay informed and elevate your role in improving patient outcomes.

Upon successful completion of this course, learners should be able to:
1. Describe recent updates in hypertension management guidelines and their implications for patient care.
2. Identify emerging therapies and evidence-based strategies pharmacists can use to optimize hypertension treatment and improve outcomes.

Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

Joseph Saseen, PharmD, BCPS, BCACP, CLS, ASH-CHC
Professor and Associate Dean for Clinical Affairs
University of Colorado

Joshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose.

Joseph Saseen is a member of the Safety Monitoring Board for CV outcome trials for Amgen. All relevant financial relationships have been mitigated.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: March 10, 2025
Planned Expiration Date: March 10, 2026

Copyright 2025, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.